Establishment Labs Holdings Inc
Suletud
SektorTervishoid
71.33 -3.78
Ülevaade
Aktsiahinna muutus
24h
Min
70.79
Max
74.45
Sissetulek | 1.6M -12M |
|---|---|
Müük | 7.7M 68M |
Aktsiakasum | -0.39 |
Kasumimarginaal | -17.394 |
Töötajad | 1,004 |
EBITDA | 4M 652K |
Järgmine tulemuste avaldamine | 4. nov 2026 |
|---|
Turukapital | -517M 2.2B |
|---|---|
Eelmine avamishind | 75.11 |
Eelmine sulgemishind | 71.33 |
Establishment Labs Holdings Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Establishment Labs Holdings Inc Prognoos
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.